跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
拓舒沃 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ivosidenib Tablets
Approved
化学药品
Ivosidenib Tablets
Servier Pharmaceuticals LLC
🇨🇳 National Medical Products Administration
Approval Date
Jan 30, 2022
Approval ID
8DqcFRyFcrF
Company
Servier Pharmaceuticals LLC
Type
化学药品
Approval Details
Approval Id
8DqcFRyFcrF
Approval Number
国药准字HJ20220002
Generic Name
艾伏尼布片
Generic Name En
Ivosidenib Tablets
Trade Name
拓舒沃
Drug Type
化学药品
Dosage Form
片剂
Strength
0.25g
Reg Date
2022-01-30
Expired Date
2027-01-29
Company Name
Servier Pharmaceuticals LLC
Production Company Name
Patheon Inc
Company Detail Path
/organization/servier-pharmaceuticals-llc
Production Company Detail Path
/organization/patheon-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 30, 2022
Approval ID
8DqcFRyFcrF
Type
化学药品
Back to NMPA Approvals